Corvus Pharmaceuticals (CRVS) Current Deferred Revenue (2015 - 2018)
Corvus Pharmaceuticals' (CRVS) quarterly Current Deferred Revenue came in at $160000.0 in Q4 2018, down 60.98% year-on-year from $410000.0 in Q4 2017, and down 63.22% quarter-over-quarter from $435000.0 in Q3 2018.
Corvus Pharmaceuticals (CRVS) Current Deferred Revenue (2015 - 2018) Analysis & Trends
Corvus Pharmaceuticals' Current Deferred Revenue history runs 4 years deep, the most recent figure standing at $160000.0 for Q4 2018.
- On a quarterly basis, Current Deferred Revenue fell 60.98% year-over-year to $160000.0 in Q4 2018; TTM through Dec 2018 was $160000.0, a 60.98% decrease from a year earlier, with the FY2018 full-year figure at $160000.0, down 60.98% from the prior year.
- Current Deferred Revenue retreated to $160000.0 in Q4 2018 per CRVS's latest filing, from $435000.0 in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $435000.0 in Q3 2018 and bottomed at $160000.0 in Q4 2018.
- The 4-year median for Current Deferred Revenue is $386000.0 (2017), against an average of $350000.0.
- Across the five-year window, Current Deferred Revenue soared 69.51% in 2016 and sank 60.98% in 2018, its largest moves.
- Year by year, Current Deferred Revenue stood at $223000.0 in 2015, then surged by 69.51% to $378000.0 in 2016, then advanced by 8.47% to $410000.0 in 2017, then sank by 60.98% to $160000.0 in 2018.
- Per Business Quant, the three latest CRVS Current Deferred Revenue figures stand at $160000.0 (Q4 2018), $435000.0 (Q3 2018), and $427000.0 (Q2 2018).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Corvus Pharmaceuticals | 1.23 Bn | 1.23 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 160,000.00 |
| Sep 30, 2018 | 435,000.00 |
| Jun 30, 2018 | 427,000.00 |
| Mar 31, 2018 | 420,000.00 |
| Dec 31, 2017 | 410,000.00 |
| Sep 30, 2017 | 402,000.00 |
| Jun 30, 2017 | 394,000.00 |
| Mar 31, 2017 | 386,000.00 |
| Dec 31, 2016 | 378,000.00 |
| Sep 30, 2016 | 311,000.00 |
| Jun 30, 2016 | 305,000.00 |
| Mar 31, 2016 | 299,000.00 |
| Dec 31, 2015 | 223,000.00 |